Skip to main content

Denali Advisors LLC

SEC CIK
0001142941
Latest filing
Aug 10, 2026

SPRY holding history

ARS Pharmaceuticals, Inc. in every 13F filed by Denali Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SPRY overviewAll 13F holders of SPRYFull Q2 2026 holdings

Shares (Q1 2024)
0
Sold out in Q1 2024
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q4 2023
Holdings of SPRY by Denali Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20240$00.0%−87,500−100.0%Sold outHolders
Q4 202387,500$479.5K0.1%+87,500NewHolders